On Monday, Integra Lifesciences Holdings Corp (NASDAQ: IART) was -21.19% drop from the session before settling in for the closing price of $16.85. A 52-week range for IART has been $14.45 – $32.66.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 1.45% over the last five years. When this article was written, the company’s average yearly earnings per share was at -6.63%. With a float of $66.10 million, this company’s outstanding shares have now reached $77.20 million.
The firm has a total of 4396 workers. Let’s measure their productivity. In terms of profitability, gross margin is 65.53%, operating margin of 2.91%, and the pretax margin is -2.65%.
Integra Lifesciences Holdings Corp (IART) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Integra Lifesciences Holdings Corp stocks. The insider ownership of Integra Lifesciences Holdings Corp is 14.38%, while institutional ownership is 92.24%. The most recent insider transaction that took place on Dec 03 ’24, was worth 100,102. In this transaction EVP, Chief Legal Officer & Sec of this company sold 4,070 shares at a rate of $24.59, taking the stock ownership to the 59,511 shares. Before that another transaction happened on Dec 03 ’24, when Company’s Officer proposed sale 4,070 for $24.59, making the entire transaction worth $100,102.
Integra Lifesciences Holdings Corp (IART) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.63% per share during the next fiscal year.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
You can see what Integra Lifesciences Holdings Corp (IART) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.63. Likewise, its price to free cash flow for the trailing twelve months is 41.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.38, a number that is poised to hit 0.51 in the next quarter and is forecasted to reach 2.64 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Analysing the last 5-days average volume posted by the [Integra Lifesciences Holdings Corp, IART], we can find that recorded value of 2.34 million was better than the volume posted last year of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 54.76%. Additionally, its Average True Range was 1.35.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 10.82%, which indicates a significant decrease from 28.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.75% in the past 14 days, which was higher than the 62.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.07, while its 200-day Moving Average is $21.75. Now, the first resistance to watch is $14.85. This is followed by the second major resistance level at $16.41. The third major resistance level sits at $18.04. If the price goes on to break the first support level at $11.66, it is likely to go to the next support level at $10.03. Now, if the price goes above the second support level, the third support stands at $8.47.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
There are 77,250K outstanding shares of the company, which has a market capitalization of 1.03 billion. As of now, sales total 1,611 M while income totals -6,940 K. Its latest quarter income was 442,650 K while its last quarter net income were 19,430 K.
